No headlines found.
No press releases found.
No news found.
Milliman Healthcare Inflation Guard ETF investment objective is to seek to generate return that over time exceed the U.S. healthcare cost inflation. The fund invests in a combination of assets that Milliman Financial Risk Management LLC, the Fund's investment adviser ("Milliman"), believes will produce returns that are generally equivalent to the U.S. healthcare cost inflation rate. The fund invests in healthcare companies include U.S.-listed common stocks and ADRs issued by companies in the healthcare sector and companies involved in the U.S. healthcare supply chain, as well as corporate bonds issued by such companies; and instruments that Milliman believes are expected to hedge against the U.S. healthcare cost inflation rate include commodities, TIPS and Treasury bonds. Milliman utilizes a proprietary quantitative model (the "Quantitative Model") that is based on its extensive research and analysis on the interrelationships and interactions of the performance of equity securities, debt securities and commodities relative to the U.S. healthcare cost inflation rate.
Milliman Healthcare Inflation Plus ETF trades on the ARCA stock market under the symbol MHIP.
As of May 13, 2026, MHIP stock price was flat at $20.01 with 21 million shares trading.
MHIP has a market cap of $1.00 million. This is considered a Sub-Micro Cap stock.
MHIP support price is $19.50 and resistance is $20.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MHIP shares will trade within this expected range on the day.
